PROTON BEAM AND PARTICLE THERAPY
THE MOST PRECISE RADIATION IN ONCOLOGY
Proton therapy is an advanced radiation treatment that precisely targets tumors with proton beams, reducing damage to healthy tissue and improving cancer treatment safety.
analyticsAt a Glance
- check_circleProton beam deposits maximum energy precisely at the tumour โ the Bragg peak
- check_circleReduces radiation dose to surrounding healthy tissue by up to 60%
- check_circleCentres in China, Japan, South Korea, the US, Germany, and the UK
- check_circleMost beneficial for brain, spine, paediatric, and head and neck tumours
What Is Particle Therapy? Proton Beam and Beyond
Particle therapy uses beams of charged particles โ most commonly protons, and for specific indications carbon ions โ rather than X-rays. The key difference is the Bragg peak: charged particles deposit most of their energy at a specific, controllable depth in tissue and then stop, leaving no exit dose beyond the tumour.
Proton Beam Therapy (PBT)
The most widely used particle therapy. Protons are hydrogen nuclei. Over 100 operational centres worldwide. Evidence base spans multiple tumour types across hundreds of clinical studies. The most clinically established form of particle therapy.
Carbon Ion Therapy (CIT)
Uses carbon atom nuclei โ much heavier than protons. Creates more intense ionization with oxygen-independent cell killing (high RBE). Particularly effective for radioresistant cancers: chordoma, chondrosarcoma, adenoid cystic carcinoma, salivary gland cancer. Available at SPHIC China, HIMAC Japan, HIT Germany.
A Brief History
Proton therapy proposed by physicist Robert Wilson in 1946; first patient treated at Lawrence Berkeley in 1954. First hospital-based centre opened at Loma Linda in 1990. Carbon ion therapy pioneered at HIMAC Japan from 1994. Now 100+ proton centres globally.
Why Paediatrics Is the Most Important Application
Children treated with radiation have decades of life ahead. Exit dose from conventional X-rays damages developing heart, lungs, bowel, and endocrine organs. Proton craniospinal irradiation reduces cardiac, pulmonary, and abdominal dose dramatically vs. photon โ directly improving long-term health outcomes.
The Physics: Why the Bragg Peak Changes Everything
The Bragg peak is the fundamental physical phenomenon that distinguishes particle therapy from conventional radiation. Understanding it explains why particle therapy protects normal tissue in a way photons cannot.
โThe Bragg peak is not a theoretical advantage โ it is a measurable, reproducible physical phenomenon that reduces dose to critical normal structures in every patient treated.โ
How X-Rays (Photons) Behave
X-rays enter the body, peak near the skin surface, then decline exponentially โ but they pass through the patient completely. To deliver adequate dose to a deep tumour, significant dose is deposited both in front of (entry) and behind (exit) the tumour in normal tissue. IMRT distributes this exit dose across multiple beam paths, but cannot eliminate it.
How Charged Particles Behave
A proton or carbon ion loses energy slowly at first, then deposits a sharp peak of energy at a specific depth (controlled by initial beam energy) โ and stops. No exit dose. Physicists position the Bragg peak precisely at the tumour by adjusting beam energy, and can spread it across the tumour volume using a spread-out Bragg peak (SOBP).
Clinical Consequence: Normal Tissue Protection
A proton beam to a brainstem tumour delivers full dose to the tumour and a dramatically reduced dose to the brainstem compared to photons. A proton craniospinal plan for medulloblastoma delivers full dose to the brain and spine while massively reducing cardiac, pulmonary, and abdominal dose โ directly impacting outcomes for a child with 60+ years of life ahead.
Which Cancers Benefit Most from Particle Therapy?
Patient selection is central to evidence-based use of particle therapy. The benefit is greatest where normal tissue sparing is clinically meaningful and the tumour dose cannot be adequately delivered with conventional radiotherapy.
| Cancer Type | Indication for Particle Therapy | Preferred Modality |
|---|---|---|
| Paediatric CNS tumours (medulloblastoma, ependymoma) | Craniospinal irradiation with minimal cardiac/pulmonary/GI dose | Proton (strongly preferred for all paediatric CSI) |
| Chordoma / Chondrosarcoma | Skull base and spine tumours adjacent to brainstem/spinal cord requiring high dose | Carbon ion preferred (higher RBE); proton accepted |
| Adenoid Cystic Carcinoma | Salivary gland/head & neck; radioresistant histology | Carbon ion (higher RBE for radioresistant tumour) |
| Uveal Melanoma | Eye tumour; extreme precision required to spare optic nerve and retina | Proton (preferred over enucleation for small/medium tumours) |
| Head & Neck (nasopharynx, H&N base of skull) | Tumours adjacent to optic nerves, brainstem, spinal cord | Proton or carbon ion depending on histology |
| Breast Cancer (left-sided) | Cardiac dose reduction vs. photon RT for left breast | Proton for selected cases with high cardiac risk |
| Prostate Cancer | Equivalent tumour control; reduced rectal and bladder dose | Proton (well-evidenced; SBRT often preferred as lower cost) |
| Lung Cancer (stage I NSCLC inoperable) | Reduced dose to heart, contralateral lung, brachial plexus | Proton for central, high-risk location tumours |
| Hepatocellular Carcinoma | High dose to tumour with minimal dose to liver parenchyma | Proton (evidence base established; CP-A/B patients) |
| Spinal and paraspinal tumours | Dose escalation adjacent to spinal cord | Proton or carbon ion |
Cost of Particle Therapy: China vs USA vs Japan
SPHIC (Shanghai) offers internationally comparable proton and carbon ion therapy at substantially lower cost. Carbon ion therapy is particularly more affordable in China and Japan than in European centres.
Proton Beam Therapy (full course)
- China (SPHIC Shanghai)USD 20,000โ40,000
- USAUSD 80,000โ180,000
- JapanUSD 50,000โ100,000
Carbon Ion Therapy (full course)
- China (SPHIC Shanghai)USD 25,000โ50,000
- Japan (HIMAC/NIRS)USD 70,000โ120,000
- Germany (HIT)USD 100,000โ150,000
How CancerFax Helps Patients Access Particle Therapy
From eligibility assessment to treatment at SPHIC or partner particle therapy centres โ end-to-end navigation.
- 1
Eligibility and Benefit Assessment
Review of imaging, pathology, and prior treatment to determine whether particle therapy offers a meaningful dosimetric advantage over photon radiotherapy for the specific clinical situation โ and whether the patients case justifies the cost and travel.
- 2
Centre Selection
For most cases, SPHIC Shanghai (proton + carbon ion) is recommended. For specific paediatric indications or cases requiring carbon ion for radioresistant histology, alternative centres in Japan or Europe may also be appropriate.
- 3
Remote Physics Consultation
SPHIC radiation oncologists and physicists can review imaging remotely to provide a treatment plan preview and dose comparison (proton vs. photon) before the patient commits to travel โ confirming that particle therapy is the right choice.
- 4
Travel and Logistics
Proton and carbon ion courses typically require 3โ7 weeks in Shanghai depending on fractionation (conventional 20โ35 fractions vs. hypofractionated 4โ5 fraction courses for some indications). CancerFax arranges accommodation near SPHIC.
- 5
Treatment Records and Follow-Up
Complete radiation treatment plan, dose-volume histograms, and follow-up schedule provided in translated form for the home radiation oncologist. Remote follow-up with SPHIC team coordinated at 3, 6, and 12 months.
Frequently Asked Questions
Proton Therapy Basics
What is proton therapy?
Proton therapy is a type of radiation treatment that uses protons instead of conventional X-rays to destroy cancer cells. Its main advantage is precision. Protons release most of their energy at a specific depth inside the body, called the Bragg peak, and then stop. This means the tumor receives a high, targeted dose while the surrounding healthy tissue is largely spared. For many patients, this approach can mean fewer side effects compared with standard radiotherapy.
How is proton therapy different from conventional radiotherapy?
Conventional radiotherapy uses photon beams that deposit radiation along their entire path, including healthy tissue beyond the tumor. Proton beams deposit very little radiation on the way in, release the bulk of their dose at the tumor, and almost nothing beyond it. This difference matters most when a tumor sits close to critical structures such as the brain, spinal cord, heart, or eyes, where protecting nearby organs is just as important as treating the cancer itself.
Which cancers can be treated with proton therapy?
Proton therapy is often considered for tumors located near sensitive organs or in children, where reducing long-term radiation exposure is a priority. Commonly treated cancers include brain and skull base tumors, head and neck cancers, pediatric cancers, certain lung and esophageal cancers, prostate cancer, liver cancer, spinal tumors, and some eye cancers. Whether it is the right choice depends on the tumor type, location, stage, and your overall treatment plan, which is why expert review is essential.
Is proton therapy better than regular radiation for everyone?
No. Proton therapy is not automatically better in every case. For some cancers, conventional radiotherapy or other treatments are equally effective and more appropriate. Proton therapy tends to offer the clearest benefit when sparing healthy tissue is critical, such as in children or tumors near vital organs. The decision should always be made by a radiation oncologist after reviewing your scans, pathology, and complete medical history.
Does proton therapy hurt, and what are the side effects?
The treatment itself is painless. You lie still while the beam is delivered, much like a regular radiation session. Side effects depend on the area being treated and may include fatigue, skin changes near the treatment site, or localised symptoms specific to that region. Because protons spare more healthy tissue, many patients experience fewer or milder side effects, though this varies from person to person.
How many proton therapy sessions are usually needed?
Most patients receive treatment over several weeks, typically as daily sessions from Monday to Friday. The exact number depends on the cancer type, size, location, and treatment goals. Some conditions may require only a few sessions, while others need several weeks. Each session usually takes a short time, though setup and positioning can add to the appointment length.
Accessibility and Cost
How much does proton therapy cost internationally?
Proton therapy generally costs more than conventional radiotherapy because of the specialised equipment and facilities involved. Costs vary widely by country, hospital, number of sessions, and the complexity of your case. Treatment in centres across China and other international destinations can offer advanced proton facilities at different price points. Because every plan is individual, CancerFax can help you obtain clear cost estimates based on your specific reports.
Is proton therapy available in India and China?
Proton therapy is available at select advanced cancer centers in both India and China, though the number of facilities remains limited compared with conventional radiotherapy. China in particular has invested heavily in proton and advanced radiation technology at several leading oncology centers. CancerFax helps patients identify suitable centers, understand availability, and coordinate access based on their diagnosis and treatment needs.
Eligibility
How do I know if I am a candidate for proton therapy?
Eligibility depends on your cancer type, tumour location, stage, prior treatments, and overall health. A radiation oncologist needs to review your imaging, pathology, and medical history to decide whether proton therapy is suitable or whether another approach would serve you better. If you are exploring this option, sharing your complete medical records allows for a proper assessment rather than a general assumption.
How CancerFax Helps?
How can CancerFax help me access proton therapy abroad?
CancerFax supports you through the full journey. This includes reviewing your medical records, arranging expert second opinions, identifying appropriate proton therapy centres, coordinating with hospitals and doctors, and helping with treatment planning, cost estimates, travel, visa support, translation, and follow-up. Our role is to help you understand your options clearly and reach confident, well-informed decisions, not to make medical decisions for you.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Could Proton or Carbon Ion Therapy Be Right for Your Cancer?
Upload your imaging and treatment records, our team will assess whether particle therapy offers a meaningful advantage for your specific diagnosis and connect you with SPHIC or the right particle therapy centre.
This content is for informational purposes only. Always consult a qualified radiation oncologist before making treatment decisions.